Skip to main content
. 2022 Feb 12;25(4):755–761. doi: 10.1038/s41391-022-00497-7

Fig. 2. Genetic-risk-adjusted cumulative incidence curves for PHS290.

Fig. 2

Curves are shown for the upper 5th (>95th) and upper 20th (>80th) percentile of PHS290 for clinically significant and non-clinically-significant prostate cancer. The reference curves represent the overall population average from the UK.